In a recent study conducted by scientists at the University of California (UC), Berkeley, the brain activity of individuals listening to Pink Floyd's "Another Brick in the Wall" has been harnessed to recreate the iconic rock track.
The findings of the study demonstrate that brainwaves can be captured and analysed to unveil musical aspects of spoken language, encompassing elements like rhythm, stress, accent, intonation, and syllabic patterns.
These musical elements are known to convey meaning in ways that spoken words alone do not. The phrase "All in all it was just a brick in the wall" could be recognised in the reproduced song, with its rhythms intact and the words muddy yet decipherable, the researchers report in the study published in the journal PLoS Biology.
The listeners were 29 patients undergoing epilepsy surgery at Albany Medical Center, New York, US, over a decade ago.
Neuroscientists at the centre recorded electrical activity through electrodes placed on the patients' brains as they heard an approximately 3-minute segment of the classic Pink Floyd song from the 1979 album The Wall.
"As this whole field of brain machine interfaces progresses, this gives you a way to add musicality to future brain implants for people who need it, someone who's got some disabling neurological or developmental disorder compromising speech output.
"It gives you an ability to decode not only the linguistic content, but some of the prosodic content of speech, some of the (emotional) affect," said Robert Knight, a neurologist and UC Berkeley professor of psychology who conducted the study with postdoctoral fellow Ludovic Bellier.
The brain machine interfaces used today to help people communicate have a robotic quality similar to how the late Stephen Hawking sounded when he used a speech-generating device, the researchers said.
Previous studies have used brain activity to reconstruct the words a person was hearing.
They have also recorded signals from the brain's motor area linked to jaw, lip and tongue movements to produce the speech intended by a paralysed patient. The words would display on a computer screen.
This study suggested that recording from the brain's auditory regions, where all aspects of sound are processed, can capture other aspects of speech important in human communication.
"Decoding from the auditory cortices, which are closer to the acoustics of the sounds, as opposed to the motor cortex, which is closer to the movements that are done to generate the acoustics of speech, is super promising," said Bellier.
"It will give a little colour to what's decoded." For the study, Bellier reanalysed brain recordings obtained in 2012 and 2013 and used artificial intelligence (specifically, nonlinear regression models) to decode brain activity and then encode a reproduction.
He and his team also pinpointed new brain regions involved in detecting rhythm, such as a thrumming guitar, and discovered that some portions (superior temporal gyrus) of the auditory cortex responded to the onset of a voice or a synthesizer, while others responded to sustained vocals.
The researchers also confirmed that the right side of the brain is more attuned to music than the left side. "Language is more left brain. Music is more distributed, with a bias toward right," Knight said.
Shefali Jariwala died at 42 in Mumbai after reportedly collapsing post-fast; cause of death suspected to be cardiac arrest or blood pressure drop.
Police found anti-ageing pills, vitamin supplements, and glutathione injections at her residence.
Doctors stress the risks of unsupervised use of hormone-based and anti-ageing treatments.
Final post-mortem report expected in two days; no foul play suspected, case treated as accidental death.
The untimely death of actor-model Shefali Jariwala has sparked renewed concern over the unregulated use of anti-ageing treatments and self-medication. The 42-year-old, best known for her appearance in Kaanta Laga, was declared dead on arrival at a Mumbai hospital on Friday night. Initial investigations suggest she may have suffered a cardiac arrest following a steep drop in blood pressure, possibly linked to taking supplements on an empty stomach.
Shefali Jariwala death raises concern over anti ageing drugs and self medication Instagram/shefalijariwala
What caused Shefali Jariwala’s collapse? Police and doctors investigate
Shefali Jariwala was rushed to Bellevue Multispeciality Hospital by her husband and friends after she suddenly collapsed at home, but she was already unresponsive. Her family said she had been fasting for a religious ritual and had consumed her regular supplements shortly after breaking the fast. Among the substances recovered at her Andheri apartment were glutathione injections, commonly used for skin lightening, and various anti-ageing tablets.
Doctors at Cooper Hospital, where her post-mortem was conducted, suspect a fatal drop in blood pressure, though only the final autopsy will confirm the precise cause of death. So far, Mumbai Police have ruled out foul play and registered an accidental death report.
Health experts warn against unmonitored anti-ageing therapies
Experts are now urging caution over the growing trend of unsupervised beauty and anti-ageing regimens, especially among public figures. Dr Dhirendra Singhania, a leading cardiologist, pointed to steroids, hormone therapies, and poor sleep as major heart risk factors, even among seemingly fit individuals. While glutathione and vitamin C aren’t inherently dangerous, he said their misuse or interaction with other drugs can trigger complications.
Anti ageing pills found at Shefali Jariwala home spark health safety debate Instagram/shefalijariwala
Shefali had no known chronic illnesses apart from epilepsy, which doctors say is unlikely to be linked to her sudden collapse. Her death, while still under investigation, adds to growing concerns about beauty pressures, self-prescribed treatments, and the long-term risks of trying to defy ageing without medical oversight.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.
Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear
• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy • Indian artisans and officials accused the brand of cultural appropriation • The footwear resembles traditional Kolhapuri chappals with GI status • Prada says designs are still in development and open to dialogue with India
Italian fashion label Prada has officially acknowledged that its Spring/Summer 2026 menswear collection includes footwear inspired by India’s traditional Kolhapuri chappals. The statement came after mounting criticism from Indian artisans and industry leaders, who claimed the brand showcased the design at Milan Fashion Week without recognising its origins.
Prada confirms Kolhapuri chappals inspired its 2026 Milan collectionInstagram/prada
Prada responds to Kolhapuri chappal row
In a letter addressed to Lalit Gandhi, President of the Maharashtra Chamber of Commerce, Industry and Agriculture (MACCIA), Prada’s CSR head Lorenzo Bertelli confirmed the sandals were influenced by Indian craftsmanship. The fashion house admitted that the open-toe leather sandals presented on the Milan runway drew from the centuries-old Kolhapuri style, traditionally made by artisans in Maharashtra and Karnataka.
Kolhapuri chappals have been crafted for centuries and received GI tag in 2019 iStock
The controversy erupted after Prada described the footwear simply as “leather sandals” in its show notes, omitting any reference to India. This led to accusations of cultural appropriation and disregard for artisans' rights. BJP MP Dhananjay Mahadik also led a group of Kolhapuri chappal makers to meet Maharashtra Chief Minister Devendra Fadnavis, urging government action to protect their Geographical Indication (GI) status.
No production yet, says Prada, as India seeks fair credit
Prada clarified that the sandals shown were part of an early-stage design process and have not been confirmed for mass production. “None of the pieces are finalised or approved for commercial use,” Bertelli wrote.
MACCIA, in its communication, called for proper acknowledgement and possible collaboration or compensation for Indian artisans. The organisation stressed that Kolhapuri chappals are not just heritage products but also vital to the livelihoods of thousands of families.
In response, Bertelli assured Prada’s commitment to ethical design, cultural respect, and further engagement with Indian artisan communities. He also welcomed the opportunity for open dialogue on potential partnerships.
The Kolhapuri chappal, awarded GI status in 2019, is a symbol of regional identity and craftsmanship. As global fashion continues to borrow from traditional cultures, this case may set the tone for how brands address ownership, recognition, and respect.
Keep ReadingShow less
Wintour’s style of leadership earned her the nickname “Nuclear Wintour”
Anna Wintour steps down as editor of US Vogue after 37 years
She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
Wintour transformed US Vogue into a global fashion authority
The 75-year-old has received numerous honours, including the Presidential Medal of Freedom
End of an era at US Vogue
Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.
The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.
A transformative legacy
Wintour took the helm of US Vogue in 1988, inheriting a relatively conservative magazine. She swiftly transformed it into a trendsetting, authoritative voice in fashion. Under her leadership, the publication became known for its iconic covers, high-end photography, and ability to shape careers in the fashion industry.
With extensive budgets and strong advertising support, Vogue became a global fashion flagship, influencing designers, celebrities, and brands worldwide.
Wintour’s style of leadership earned her the nickname “Nuclear Wintour” for her decisiveness, with some reports noting her tendency to make bold editorial decisions without extensive discussion. Her distinctive bob haircut and ever-present sunglasses made her a recognisable front-row figure at fashion weeks around the world.
Beyond the magazine
The British-born editor rose to wider public fame as the inspiration behind the character Miranda Priestly in The Devil Wears Prada — both the 2003 novel and the 2006 film adaptation. While Wintour rarely commented on the portrayal, she acknowledged the attention it brought, most recently during the launch of a stage musical adaptation in London in 2024.
She told the BBC, “They [my sunglasses] help me see and they help me not see. They help me be seen and not be seen. They are a prop, I would say.”
Wintour also became synonymous with the Met Gala, the annual high-profile charity event in New York City, which she has organised for years, drawing celebrities from fashion, film, politics, and sport.
Recognition and future plans
Wintour has received numerous accolades during her career. She was made a Dame Commander of the Order of the British Empire (DBE) in 2017 and became a Companion of Honour in February 2025. During the ceremony in London, she removed her sunglasses to receive the award and told King Charles III that she had no intention of retiring.
Wintour also became synonymous with the Met GalaGetty Images
In the United States, President Joe Biden awarded her the Presidential Medal of Freedom earlier this year before leaving office.
Despite stepping back from US Vogue, Wintour will continue to oversee several major Condé Nast titles including Wired, Vanity Fair, GQ, Condé Nast Traveler, and Glamour, as part of her global leadership responsibilities.
In her remarks to staff, she described the decision as “pivotal” but confirmed she would not be leaving the company or her office. “I’ll be turning all my attention to global leadership and working with our team of brilliant editors around the world,” she said.
Nadiya Hussain confirms BBC will not renew her cookery series
Bake Off winner challenges expectations to remain “grateful”
She says hard work and talent, not luck, brought her success
Celebrities, including Annie Lennox and Fearne Cotton, show support
BBC ends decade-long collaboration with Bake Off star
Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.
The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.
“Gratitude shouldn't be a muzzle”
In a video message posted on Instagram, Hussain said she had received numerous messages urging her to be grateful following the show's cancellation. She described how growing up in an immigrant household had shaped her understanding of gratitude.
“Grateful for being let in, grateful for having work—even if underpaid, grateful for safety—even if it meant silence,” she explained. “Gratitude became something that I was expected to wear like a uniform.”
She continued: “I am allowed to feel more than just thankful. I am a human being, and I am allowed to feel angry when I’m treated unfairly. I’m allowed to want better for myself and for my family.”
Challenging the idea that people from marginalised backgrounds must constantly express gratitude for any opportunities, she said: “We didn’t come here just to survive; we came here to live, to grow, to contribute, to belong—not as a guest, but as a person who has rights and dreams and dignity.”
Hussain concluded, “So no, I won’t always be grateful. I got here through hard work, through determination, through talent. I got here because I’m good at what I do.”
Nadiya’s message received widespread support from fans and fellow public figures. TV presenter Fearne Cotton responded with a series of heart emojis, while musician Annie Lennox praised her statement, writing: “Gratitude should never become a silencing muzzle—as you so rightly say!”
Rahul Mandal, who won Bake Off in 2018, commented: “So true. Thanks so much for speaking up.” TV doctor Amir Khan also backed her remarks, stating: “Exactly this! Well said.”
Nadiya’s track record with the BBC
Since winning Bake Off when it aired on the BBC, Hussain has fronted several successful cookery series for the broadcaster. These include Nadiya Bakes, Nadiya’s Fast Flavours, and Nadiya’s Simple Spices. She is also a published author of cookbooks and children’s titles.
Earlier this month, the BBC issued a statement on the programming decision: “After several wonderful series, we have made the difficult decision not to commission another cookery show with Nadiya Hussain at the moment.”
However, the broadcaster emphasised that it remains open to future collaborations and that Nadiya is “a much-valued part of the BBC family”.
What’s next for Nadiya?
While a new BBC project is not in the pipeline, Nadiya has hinted at future ventures. In a previous post addressing the show’s cancellation, she said she is now focusing on “being [her] most authentic self” and is looking forward to working with people who “believe in [her] talent”.
She also reassured her followers that “exciting” new projects are on the way.
Keep ReadingShow less
The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow
Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
Health officials are investigating possible genetic causes behind the side-effects
Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
Adverse drug reactions cost the NHS an estimated £2.2bn annually
Health watchdog investigates spike in serious side-effects from GLP-1 drugs
UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.
The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.
What is acute pancreatitis?
Acute pancreatitis is a sudden inflammation of the pancreas, the gland located behind the stomach that helps with digestion. Symptoms typically include severe abdominal pain, nausea, and fever, and the condition often requires hospital treatment. In rare cases, it can be fatal.
Though pancreatitis is listed as an “uncommon” side-effect of GLP-1 medications in patient information leaflets – meaning it may affect around one in 100 people – the MHRA has seen a notable rise in reported incidents, particularly in 2025.
Since the start of the year, there have been 22 reports involving semaglutide (Ozempic and Wegovy) and 101 involving tirzepatide (Mounjaro).
Study launched to explore potential genetic link
To understand the possible causes of these side effects, particularly in light of rising usage of these medications, the MHRA is inviting affected patients to take part in a research study through the Yellow Card Biobank. The initiative, run by Genomics England, will collect saliva samples and other data to explore any genetic factors that may be influencing patient response to GLP-1 drugs.
An MHRA spokesperson stated: “Alongside increased usage, we are seeing an upturn in the number of Yellow Card reports mentioning GLP-1 medicines and acute pancreatitis.”
While no known genetic link has yet been established, the MHRA said genetic variations could help explain why some patients experience adverse reactions to certain medications. The agency is urging both patients and health professionals to report suspected side-effects related to these drugs.
Adverse reactions place burden on NHS
Research shows that one in six hospital admissions is caused by an adverse drug reaction, and around a third of those could potentially be avoided through genetic testing. The financial cost is also significant – the NHS spends over £2.2 billion each year on hospital stays linked to adverse reactions alone.
Dr Alison Cave, chief safety officer at the MHRA, highlighted the need for more personalised approaches to medicine: “Evidence shows that almost a third of side-effects to medicines could be prevented with the introduction of genetic testing.”
Manufacturers respond to rising concerns
In response to the reports, drugmakers Lilly and Novo Nordisk reiterated their commitment to patient safety and advised that side effects should always be reported and discussed with healthcare professionals.
A spokesperson for Lilly, which manufactures Mounjaro, said: “Patient safety is Lilly’s top priority. We take reports seriously and actively monitor, evaluate and report safety information for all our medicines.”
The Mounjaro leaflet identifies acute pancreatitis as an uncommon side-effect, advising patients to consult their doctor before using the drug if they have a history of the condition.
Novo Nordisk UK, which produces Ozempic and Wegovy, issued a similar statement: “Patient safety is of the utmost importance to Novo Nordisk… The known risks and benefits of GLP-1 medicines are described in the product information. We recommend that patients take these medications only for their approved indications and under the strict supervision of a healthcare professional.”
Both companies said they were continuously collecting safety data and working with authorities to ensure ongoing monitoring and understanding of their treatments.
What should patients do?
Health officials are encouraging patients who have experienced severe symptoms such as abdominal pain, nausea, or fever after taking these medications to report their experiences to the Yellow Card scheme. Hospitalised individuals may be contacted to participate in the Biobank study.
While the overall safety profile of GLP-1 medicines remains positive, the MHRA has stressed the importance of vigilance as demand for these weight loss and diabetes drugs continues to grow.